Changes in umbilical artery flow velocity waveforms following maternal administration of betamethasone

Placenta

Volumn 24, Issue 1, 2003, Pages 12-16

  Edwards, Andrew ^a   Baker, Lesleigh S ^a   Wallace, Euan M ^a,b  

^a MONASH MEDICAL CENTRE   (Australia)

^b MONASH UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

BETAMETHASONE; STEROID;

ARTERY BLOOD FLOW; ARTICLE; BLOOD FLOW VELOCITY; COLOR ULTRASOUND FLOWMETRY; CONTROLLED STUDY; DIASTOLE; DRUG MECHANISM; FEMALE; FETOPLACENTAL UNIT; HIGH RISK PREGNANCY; HUMAN; HYPERTENSION; INTRAUTERINE GROWTH RETARDATION; NEONATAL RESPIRATORY DISTRESS SYNDROME; NEWBORN DEATH; PREGNANCY COMPLICATION; PRIORITY JOURNAL; PROSPECTIVE STUDY; STILLBIRTH; UMBILICAL ARTERY; UMBILICAL CORD BLOOD FLOW; VASCULAR RESISTANCE; WAVEFORM;

EID: 0141726788     PISSN: 01434004     EISSN: None     Source Type: Journal    
DOI: 10.1053/plac.2002.0874     Document Type: Article

References (26)

1. Adamson SL (1999) Arterial pressure, vascular input impedance, and resistance as determinants of pulsatile blood flow in the umbilical artery. Eur J Obstet Gynecol Reprod Biol, 84, 119-125.
2. Adamson SL & Kingdom J (1999) Antenatal betamethasone and fetoplacental blood flow (letter). Lancet, 354, 255-256.
3. Arduini D, Rizzo G, Romanini C & Mancuso S (1987) Fetal blood flow velocity waveforms as predictors of growth retardation. Obstet Gynecol, 70, 7-10.
4. Ballard PL & Ballard RA (1995) Scientific basis and therapeutic regimens for use of antenatal glucocorticoids. Am J Obstet Gynecol, 173, 254-262.
5. Burns PN (1987) Doppler flow estimations in the fetal and maternal circulations: principles, techniques, and some limitations. In Doppler ultrasound measurements of maternal fetal haemodynamics (Eds) Maulik D & McNellis DH, pp. 43-76. New York: Perinatology Press.
6. Clifton VL, Read MA, Leitch IM, et al. (1994) Corticotropin-releasing hormone-induced vasodilatation in the human fetal-placental circulation. J Clin Endocrinol Metab, 76, 666-669.
7. Clifton VL, Wallace EM & Smith R (2002) Short term effects of glucocorticoids in the human fetal-placental circulation in vitro. J Clin Endocrinol Metabol, 87, 2838-2842.
8. Cohlen BJ, Stigter RH, Derks JB, Mulder EJH & Visser GHA (1996) Absence of significant haemodynamic changes in the fetus following betamethasone administration. Ultrasound Obstet Gynaecol, 8, 252-255.
9. Denison FC, Elliott CL & Wallace EM (1997) Dexamethasone-induced leucocytosis in pregnancy. Brit J Obstet Gynaecol, 104, 851-853.
10. Edwards E, Megens A, Peek M & Wallace EM (2000) Sexual origins of placental dysfunction. Lancet, 355, 203-204.
11. Giles WB, Trudinger BJ & Baird PJ (1985) Fetal umbilical artery flow velocity waveforms and placental resistance:pathological correlation. Brit J Obstet Gynaecol, 92, 31-38.
12. Harper A & Murnaghan GA (1991) Maternal and fetal haemodynamics in hypertensive pregnancies during maternal treatment with intravenous hydralazine or labetalol. Brit J Obstet Gynaecol 1991, 98, 453-459.
13. Kari MA, Hallman M, Eronen M, Teramo K, Virtanen M, Koivisto M & Ikonen RS (1994) Prenatal dexamethasone treatment in conjunction with rescue therapy of human surfactant: a randomised placebo-controlled multicenter study. Pediatrics, 93, 730-736.
14. Kelly MK, Schneider EP, Petrikovsky BM & Lesser ML (2000) Effect of antenatal steroid administration on the fetal biophysical profile. J Clin Ultrasound, 28, 224-226.
15. Kingdom J & Smith G (2000) Diagnosis and management of IUGR. In Intrauterine growth restriction. Aetiology and management (Eds) Kingdom J & Baker P, pp. 257-273. London: Springer-Verlag.
16. Krebs C, Macara LM, Leiser R, Bowman AW, Greer IA & Kingdom JC (1996) Intrauterine growth restriction with absent end-diastolic flow velocity in the umbilical artery is associated with maldevelopment of the placental terminal villous tree. Am J Obstet Gynecol, 175, 1534-1542.
17. Magee LA, Dawes GS, Moulden M & Redman CW (1997) A randomised controlled comparison of betamethasone with dexamethasone: effects on the antenatal fetal heart rate. Br J Obstet Gynaecol, 104, 1233-1238.
18. Mulder EJ, Derks JB & Visser GH (1997) Antenatal corticosteroid therapy and fetal behaviour: a randomised study of the effects of betamethasone and dexamethasone. Br J Obstet Gynaecol, 104, 1239-1247.
19. Neilson JP & Alfirevic Z (1998) Doppler ultrasound in high-risk pregnancies. In Pregnancy and Childbirth Module of The Cochrane Database of Systematic Reviews (Eds) Neilson JP, Crowther CA, Hodnett ED & Hofmeyr GJ, The Cochrane Collaboration; issue 1. Oxford: Update Software.
20. Roberts CL & Lancaster PA (1999) Australian national birthweight percentiles by gestational age. Med J Aust, 170, 114-118.
21. Rotmensch S, Liberati M, Vishne TH, Celentano C, Ben-Rafael Z & Bellati U (1999) The effect of betamethasone and dexamethasone on fetal heart rate patterns biophysical activities. A prospective randomized trial. Acta Obstet Gynaecol Scand, 78, 493-500.
22. Sebire NJ, Goldin RD & Regan L (2001) Histomorphological evidence for chronic vasoconstriction of placental stem vessels in pregnancies with intrauterine growth restriction and abnormal umbilical artery Doppler velocimetry indices (Abstract). J Pathol, 195, 19A.
23. Sebire NJ & Talbert DG (2001) The dynamic placenta: a closer look at the pathophysiology of placental hemodynamics in uteroplacental compromise. Ultrasound Obstet Gynecol, 18, 557-561.
24. Sivan E, Dulitzky M, Lipitz S, et al. (1995) The clinical value of umbilical artery Doppler velocimetry in the management of intrauterine growth retarded fetus before 32 weeks' gestation. Gynecol Obstet Invest, 40, 19-23.
25. Wallace EM & Baker LS (1999) Effect of antenatal betamethasone administration on placental vascular resistance. Lancet, 353, 1404-1407.
26. Wallace EM, Ekkel K, Cotter T, Tippett C & Catalano J (1998) Haematological effects of betamethasone treatment in late pregnancy. Aus NZ J Obstet Gynaecol, 38, 396-398.